L57 – Neuroscience Peptides
The blood-brain barrier (BBB) is a major obstacle to drug delivery into the central nervous system (CNS), in particular for macromolecules such as peptides and proteins. However, certain macromolecules can reach the CNS via a receptor-mediated transcytosis (RMT) pathway, and low-density lipoprotein receptor-related protein 1 (LRP1) is one of the promising receptors for RMT. L57 can therefore be used for the development of RMT-based drugs for the treatment of CNS diseases.
Technical specification
| Sequence : | H-TWPKHFDKHTFYSILKLGKH-OH | |
| MW : | 2.842.3 g/mol | |
| Purity : | > 95% | |
| Counter-Ion : | TFA Salts | |
| Delivery format : | Lyophilized |
Price
| Product | Size | Price € | Price $ |
| CRB1001192-0.5 mg | 0.5 mg | 141€ | 170$ |
| CRB1001192-1 mg | 1 mg | 193€ | 232$ |
